Related Experiment Video
Updated: Aug 4, 2026

12:18
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
23.4K
Methicillin-resistant Staphylococcus aureus in Nepal: A systematic review and meta-analysis
Ashok Khanal1, Sulochan G C2, Amrit Gaire2
1Maharajgunj Medical Campus, Tribhuvan University Institute of Medicine, Kathmandu, Nepal; Active Pharmacy Pvt. Ltd., Kathmandu, Nepal.
Summary
Methicillin-resistant Staphylococcus aureus (MRSA) is a significant health threat in Nepal, with a prevalence of 38.2% among S. aureus isolates. Urgent interventions are needed to combat this growing antimicrobial resistance crisis.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a global health challenge, particularly in developing nations like Nepal.
- Low healthcare standards and antibiotic misuse contribute to the prevalence of MRSA in Nepalese hospitals.
- MRSA strains are frequently detected but often underreported in Nepal.
Purpose of the Study:
- To systematically review and analyze the prevalence of MRSA in Nepal.
- To evaluate the antimicrobial susceptibility patterns of MRSA strains in the country.
- To provide a national-level understanding of the MRSA burden.
Main Methods:
- A systematic review and meta-analysis of studies published between 2008 and 2020.
- Searches conducted across major databases including PubMed, EMBASE, Cochrane CENTRAL, Google Scholar, and Nepalese databases.
- Quantitative analysis of 26 selected original articles using specialized meta-analysis software.
Main Results:
- The pooled prevalence of MRSA infections was 38.2% (95% CI, 31.4%-45.2%) among 5951 S. aureus isolates.
- Significant heterogeneity was observed (I² = 96.7%), with no evidence of publication bias.
- MRSA strains exhibited high resistance to beta-lactam antibiotics, with high susceptibility to vancomycin (98.0%) and chloramphenicol (91.0%).
Conclusions:
- The overall burden of MRSA in Nepal is substantial and shows an increasing trend.
- Effective control strategies require sound legislation and defined antibiotic policies.
- Implementing control interventions is crucial for managing MRSA and broader antimicrobial resistance.
Related Concept Videos
Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...

